Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Anika Therapeutics Management to Present at Upcoming Investment Conferences in December 2024

Anika Therapeutics announces participation in investment conferences, showcasing management and discussing orthopedic advancements.Quiver AI SummaryAnika Therapeutics, Inc. has announced that its senior...

ANIK : 16.31 (-0.12%)
Anika To Participate in December 2024 Investor Conferences

ANIK : 16.31 (-0.12%)
New Strong Sell Stocks for November 11th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:A-Mark Precious Metals, Inc. AMRK is a precious metals trading company. The Zacks Consensus Estimate for its current year earnings...

ANIK : 16.31 (-0.12%)
AMRK : 25.79 (-1.00%)
ALG : 188.34 (-3.17%)
Anika: Q3 Earnings Snapshot

Anika: Q3 Earnings Snapshot

ANIK : 16.31 (-0.12%)
Anika Reports Third Quarter 2024 Financial Results

ANIK : 16.31 (-0.12%)
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

ANIK : 16.31 (-0.12%)
Anika Announces Third Quarter 2024 Results Conference Call Date

ANIK : 16.31 (-0.12%)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ANIK : 16.31 (-0.12%)
Anika: Q2 Earnings Snapshot

Anika: Q2 Earnings Snapshot

ANIK : 16.31 (-0.12%)
Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc®

/CNW/ - Pendopharm, a division of Pharmascience Canada ("Pendopharm"), is pleased to announce the renewal of its exclusive distribution agreement with Anika...

ANIK : 16.31 (-0.12%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar